To validate the strong associations between the C421A polymorphism in ABCG2 and the cancer risk, Daniele Campa and his colleagues extracted date from two previous GWAS on CLL (chronic lymphocytic leukemia) [40,41]. This evidence concerns the gene ABCG2 and B-cell chronic lymphocytic leukemia.